NCT04856059Recruiting
Fabry Cardiomyopathy: Identification of Early Myocardial Structural and Tissue Abnormalities Using Multiparametric MRI
Source: ClinicalTrials.gov · Last updated 16 Apr 2026
Brief summary (registry, in English)
This study will evaluate whether cardiac MRI T1 and T2 mapping improves our ability to detect early abnormalities in the heart in patients with Fabry disease and identify patients at increase risk of adverse events.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- First submitted
- 20 Apr 2021
- Start date
- 15 Jun 2021
- Primary completion date
- 31 Mar 2029
- Lead sponsor
- University Health Network, Toronto
- Diseases
- Fabry disease
- NCT number
- NCT04856059
What you commit to
- Study type: Interventional
- Planned participants: 300
- From 15 Jun 2021 to the primary completion date, 31 Mar 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of myocardial infarction;
Other
- Contraindication to MRI.
Who the study is looking for
- Fabry disease;
- Age ≥ 18 years.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Health Network Coordinator of this site? Confirm its status | Toronto | Canada | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.